Ocugen, Inc. (OCGN)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Ocugen, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Ocugen, Inc. (OCGN) has returned 34.07% so far this year and 156.27% over the past 12 months. Over the last ten years, OCGN has returned -35.42% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.

Based on dividend-adjusted daily data since Dec 3, 2014, OCGN's average daily return is +0.19%, while the average monthly return is +5.94%. At this rate, your investment would double in approximately 1.0 years.

Historically, 39% of months were positive and 61% were negative. The best month was Feb 2021 with a return of +518.6%, while the worst month was Sep 2018 at -81.3%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 9 months.

On a daily basis, OCGN closed higher 43% of trading days. The best single day was Dec 23, 2020 with a return of +222.9%, while the worst single day was Sep 5, 2018 at -72.6%.

Ocugen, Inc. has an annualized alpha of 37.67%, beta of 1.28, and R² of 0.02 versus S&P 500 Index. Calculated based on daily prices since December 04, 2014.

• This stock participated in 213.80% of S&P 500 Index downside but only -5.39% of its upside — more exposed to losses than it benefited from rallies.
• R² of 0.02 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

OCGN ranks 86 for risk / return — in the top 86% of stocks on our site. This means strong returns relative to risk — exactly what professional investors look for. Well-suited for investors who want to maximize return per unit of risk.

The table below present risk-adjusted performance metrics for Ocugen, Inc. (OCGN) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Ocugen, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Ocugen, Inc. was 99.97%, occurring on Jul 14, 2020. The portfolio has not yet recovered.

The current Ocugen, Inc. drawdown is 99.74%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Ocugen, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Ocugen, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.